Advances in respiratory medicine最新文献

{"title":"Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease.","authors":"Ryota Otoshi,&nbsp;Akimasa Sekine,&nbsp;Tatsuya Muraoka,&nbsp;Tae Iwasawa,&nbsp;Tamiko Takemura,&nbsp;Shoichiro Matsushita,&nbsp;Koji Okudela,&nbsp;Hideya Kitamura,&nbsp;Tomohisa Baba,&nbsp;Takashi Ogura","doi":"10.3390/arm91020014","DOIUrl":"https://doi.org/10.3390/arm91020014","url":null,"abstract":"<p><strong>Introduction: </strong>Idiopathic multicentric Castleman disease (MCD) has been reported to form lung cysts at a relatively high rate. However, the radiological and pathological features of cystic formation in MCD are unclear.</p><p><strong>Methods: </strong>To clarify these questions, we retrospectively investigated the radiological and pathological findings of cysts in MCD patients. Eight consecutive patients who underwent surgical lung biopsies in our center from 2000 to 2019 were included.</p><p><strong>Results: </strong>The median age was 44.5 years, with three males and five females. On the initial computed tomography, cyst formation was found in seven patients (87.5%). All of the cysts were multiple, round, and thin walled, accompanying ground-glass attenuation (GGA) around cysts. In six patients (75%), cysts increased during their clinical courses, and the new cysts had emerged from GGA, although GGA was improved by treatment. In all four cases, whose pulmonary cysts could be pathologically evaluated, a marked plasma cell infiltration around the cyst wall, and loss of elastic fibers of the alveolar wall were observed.</p><p><strong>Conclusions: </strong>Pulmonary cysts emerged in the area of GGA pathologically consistent with plasma cell infiltration. Cysts in MCD may be formed by the loss of elastic fibers due to marked plasma cell infiltration and may be considered irreversible changes.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 2","pages":"164-173"},"PeriodicalIF":1.8,"publicationDate":"2023-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9368842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases.","authors":"Krishna Pillai,&nbsp;Ahmed H Mekkawy,&nbsp;Javed Akhter,&nbsp;David L Morris","doi":"10.3390/arm91020013","DOIUrl":"10.3390/arm91020013","url":null,"abstract":"<p><p>Respiratory diseases such as cystic fibrosis, COPD, and COVID-19 are difficult to treat owing to viscous secretions in the airways that evade mucocilliary clearance. Earlier studies have shown success with BromAc as a mucolytic agent. Hence, we tested the formulation on two gelatinous airway representative sputa models, to determine whether similar efficacy exist. Sputum lodged in an endotracheal tube was treated to aerosol N-acetylcysteine, bromelain, or their combination (BromAc). After measuring the particle size of aerosolized BromAc, the apparent viscosity was measured using a capillary tube method, whilst the sputum flow was assessed using a 0.5 mL pipette. Further, the concentration of the agents in the sputa after treatment were quantified using chromogenic assays. The interaction index of the different formulations was also determined. Results indicated that the mean particle size of BromAc was suitable for aerosol delivery. Bromelain and N-acetylcysteine affected both the viscosities and pipette flow in the two sputa models. BromAc showed a greater rheological effect on both the sputa models compared to individual agents. Further, a correlation was found between the rheological effects and the concentration of agents in the sputa. The combination index using viscosity measurements showed synergy only with 250 µg/mL bromelain + 20 mg/mL NAC whilst flow speed showed synergy for both combinations of bromelain (125 and 250 µg/mL) with 20 mg/mL NAC. Hence, this study indicates that BromAc may be used as a successful mucolytic for clearing airway congestion caused by thick mucinous immobile secretions.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 2","pages":"146-163"},"PeriodicalIF":1.8,"publicationDate":"2023-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135762/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9368845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathogenic Role and Antibiotic Resistance of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Strains Causing Severe Community-Acquired Pneumonia in Vietnamese Children.","authors":"Khai Quang Tran, Thuy Thi Dieu Nguyen, Van Hung Pham, Quan Minh Pham, Hung Do Tran","doi":"10.3390/arm91020012","DOIUrl":"10.3390/arm91020012","url":null,"abstract":"<p><p>In recent years, the pathogenic role and antibiotic resistance of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) strains causing severe community-acquired pneumonia (CAP) have received increasing attention in clinical practice. The aim of this study was to determine the rate of isolates of MRSA strains causing severe CAP in children and to assess their level of antibiotic resistance. The study design was cross-sectional. Children with severe CAP were sampled by nasopharyngeal aspiration for the culture, isolation, and identification of MRSA. Antimicrobial susceptibility testing was performed using the gradient diffusion method to determine the minimum inhibitory concentration (MIC) of antibiotics. Results: MRSA was identified as the second leading cause of severe CAP in Vietnamese children. The rate of isolates of <i>S. aureus</i> was 41/239 (17.5%), of which most were MRSA, at 32/41 (78.0%). MRSA strains were completely non-susceptible to penicillin (100%), more resistant to clindamycin and erythromycin, less sensitive to ciprofloxacin and levofloxacin, and fully susceptible to vancomycin and linezolid, with a 32-fold decreased MIC₉₀ for vancomycin (0.5 mg/L) and a 2-fold decreased MIC₉₀ for linezolid (4 mg/L). Therefore, vancomycin and linezolid may be appropriate options for severe CAP identified by MRSA.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 2","pages":"135-145"},"PeriodicalIF":1.8,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9368844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease.","authors":"Mandeep Singh Rahi,&nbsp;Bright Thilagar,&nbsp;Swetha Balaji,&nbsp;Sivaguha Yadunath Prabhakaran,&nbsp;Mayuri Mudgal,&nbsp;Suganiya Rajoo,&nbsp;Prashanth Reddy Yella,&nbsp;Palak Satija,&nbsp;Alsu Zagorulko,&nbsp;Kulothungan Gunasekaran","doi":"10.3390/arm91020011","DOIUrl":"https://doi.org/10.3390/arm91020011","url":null,"abstract":"<p><p>Patients with COPD (chronic obstructive pulmonary disease) are at a higher risk of comorbid conditions such as anxiety and/or depression, which in turn increase their symptom burden and rehospitalizations compared to the general population. It is important to investigate the pathophysiology and clinical implications of mental health on patients with COPD. This review article finds that COPD patients with anxiety and/or depression have a higher rehospitalization incidence. It reviews the current screening and diagnosis methods available. There are pharmacological and non-pharmacologic interventions available for treatment of COPD patients with depression based on severity. COPD patients with mild depression benefit from pulmonary rehabilitation and cognitive behavioral therapy, whereas patients with severe or persistent depression can be treated with pharmacologic interventions.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 2","pages":"123-134"},"PeriodicalIF":1.8,"publicationDate":"2023-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9554277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosing Lung Abnormalities Related to Heart Failure in Chest Radiogram, Lung Ultrasound and Thoracic Computed Tomography.","authors":"Dominika Siwik,&nbsp;Wojciech Apanasiewicz,&nbsp;Małgorzata Żukowska,&nbsp;Grzegorz Jaczewski,&nbsp;Marta Dąbrowska","doi":"10.3390/arm91020010","DOIUrl":"https://doi.org/10.3390/arm91020010","url":null,"abstract":"<p><p>Heart failure (HF) is a multidisciplinary disease affecting almost 1-2% of the adult population worldwide. Symptoms most frequently reported by patients suffering from HF include dyspnoea, cough or exercise intolerance, which is equally often observed in many pulmonary diseases. The spectrum of lung changes related to HF is wide. The knowledge of different types of these abnormalities is essential to distinguish patients with HF from patients with lung diseases or both disorders and thus avoid unnecessary diagnostics or therapies. In this review, we aimed to summarise recent research concerning the spectrum of lung abnormalities related to HF in three frequently used lung imaging techniques: chest X-ray (CXR), lung ultrasound (LUS) and chest computed tomography (CT). We discussed the most prevalent abnormalities in the above-mentioned investigations in the context of consecutive pathophysiological stages identified in HF: (i) redistribution, (ii) interstitial oedema, and (iii) alveolar oedema. Finally, we compared the utility of these imaging tools in the clinical setting. In conclusion, we consider LUS the most useful and promising imaging technique due to its high sensitivity, repeatability and accessibility. However, the value of CXR and chest CT is their potential for establishing a differential diagnosis.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 2","pages":"103-122"},"PeriodicalIF":1.8,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9186509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inspiratory-Expiratory Muscle Training Improved Respiratory Muscle Strength in Dialysis Patients: A Pilot Randomised Trial.","authors":"Nicola Lamberti,&nbsp;Giovanni Piva,&nbsp;Yuri Battaglia,&nbsp;Michele Franchi,&nbsp;Matteo Pizzolato,&nbsp;Antonio Argentoni,&nbsp;Giorgio Gandolfi,&nbsp;Giulia Gozzi,&nbsp;Margherita Lembo,&nbsp;Pietro Lavisci,&nbsp;Alda Storari,&nbsp;Natascia Rinaldo,&nbsp;Fabio Manfredini,&nbsp;Annalisa Cogo","doi":"10.3390/arm91010009","DOIUrl":"https://doi.org/10.3390/arm91010009","url":null,"abstract":"<p><p>End-stage kidney disease (ESKD) exposes patients to progressive physical deconditioning involving the respiratory muscles. The aim of this pilot randomized controlled trial was to determine the feasibility and effectiveness of low-intensity respiratory muscle training (RMT) learned at the hospital and performed at home. A group of ESKD patients (<i>n</i> = 22) were randomized into RMT or usual care (control group, CON) in a 1:1 ratio. The respiratory training was performed at home with an inspiratory-expiratory system for a total of 5 min of breathing exercises in a precise rhythm (8 breaths per minute) interspersed with 1 min of rest, two times per day on nondialysis days for a total of 4 weeks, with the air resistance progressively increasing. Outcome measures were carried out every 4 weeks for 3 consecutive months, with the training executed from the 5th to the 8th week. Primary outcomes were maximal inspiratory and expiratory pressure (MIP, MEP), while secondary outcomes were lung capacity (FEV1, FVC, MVV). Nineteen patients without baseline between-group differences completed the trial (T: <i>n</i> = 10; Age: 63 ± 10; Males: <i>n</i> = 12). Both MIP and MEP significantly improved at the end of training in the T group only, with a significant difference of MEP of 23 cmH₂O in favor of the RMT group (<i>p</i> = 0.008). No significant variations were obtained for FVC, FEV1 or MVV in either group, but there was a greater decreasing trend over time for the CON group, particularly for FVC (t = -2.00; <i>p</i> = 0.046). Low-fatiguing home-based RMT, with a simple device involving both inspiratory and expiratory muscles, may significantly increase respiratory muscle strength.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 1","pages":"93-102"},"PeriodicalIF":1.8,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10782419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece.","authors":"Marios Spanakis,&nbsp;Petros Ioannou,&nbsp;Sotiris Tzalis,&nbsp;Flora Chouzouri,&nbsp;Evridiki Patelarou,&nbsp;Diamantis P Kofteridis,&nbsp;Katerina M Antoniou,&nbsp;Sophia E Schiza,&nbsp;Athina Patelarou,&nbsp;Nikos Tzanakis","doi":"10.3390/arm91010008","DOIUrl":"https://doi.org/10.3390/arm91010008","url":null,"abstract":"<p><p><i>Background</i>: Patients with respiratory disorders often have additional diseases and are usually treated with more than one medication to manage their respiratory conditions as well as additional comorbidities. Thus, they are frequently exposed to polypharmacy (≥5 drugs), which raises the risk for drug-drug interactions (DDIs) and adverse drug reactions (ADRs). In this work, we present the results regarding the prevalence of DDIs in hospitalized patients with respiratory disorders in Greece. <i>Methods</i>: A 6-month descriptive single-center retrospective observational study enrolled 102 patients with acute or chronic respiratory disorders. Clinical characteristics and medication regimens were recorded upon admission, hospitalization, and discharge. The prevalence of DDIs and their clinical significance was recorded and analyzed. <i>Results</i>: Unspecified acute lower respiratory tract infection (25%), exacerbations of chronic obstructive pulmonary disease (12%) and pneumonia (8%) were the most frequent reasons for admission. Cardiovascular disorders (46%), co-existing respiratory disorders (32%), and diabetes (25%) were the most prevalent comorbidities. Polypharmacy was noted in 61% of patients upon admission, 98% during hospitalization, and 63% upon discharge. Associated DDIs were estimated to be 55% upon admission, 96% throughout hospitalization, and 63% on discharge. Pharmacodynamic (PD) DDIs were the most prevalent cases (81%) and referred mostly to potential risk for QT-prolongation (31.4% of PD-DDIs) or modulation of coagulation process as expressed through the international normalized ratio (INR) (29.0% of DDIs). Pharmacokinetic (PK) DDIs (19% of DDIs) were due to inhibition of Cytochrome P450 mediated metabolism that could lead to elevated systemic drug concentrations. Clinically significant DDIs characterized as \"serious-use alternative\" related to 7% of cases while 59% of DDIs referred to combinations that could be characterized as \"use with caution-monitor\". Clinically significant DDIs mostly referred to medication regimens upon admission and discharge and were associated with outpatient prescriptions. <i>Conclusions:</i> Hospitalized patients with respiratory disorders often experience multimorbidity and polypharmacy that raise the risk of DDIs. Clinicians should be conscious especially if any occurring arrhythmias, INR modulations, and prolonged or increased drug action is associated with DDIs.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 1","pages":"74-92"},"PeriodicalIF":1.8,"publicationDate":"2023-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10782418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Asthma and Fixed Airways Obstruction: Real Life Aspects.","authors":"Enrico Buonamico,&nbsp;Andrea Portacci,&nbsp;Silvano Dragonieri,&nbsp;Vitaliano Nicola Quaranta,&nbsp;Fabrizio Diaferia,&nbsp;Elena Capozza,&nbsp;Luigi Macchia,&nbsp;Giovanna Elisiana Carpagnano","doi":"10.3390/arm91010007","DOIUrl":"https://doi.org/10.3390/arm91010007","url":null,"abstract":"<p><p>We aimed to evaluate asthmatic patients with fixed airways obstruction (FAO) and to verify the impact of follow-up in an asthma-dedicated outpatient clinic on symptoms control and spirometry compared to asthmatics without FAO. We enrolled 20 asthmatic FAO+ patients and 20 FAO- asthmatics at baseline (T0) and at a one-year follow-up visit (T1). FAO+ and FAO- groups were compared for anamnesis, FEV1, asthma control test (ACT) and their ΔT0-T1. FAO+ and FAO- groups did not differ for age, BMI, pack-years, allergy, T0 blood eosinophils, comorbidities or GINA therapy step at T0 and T1, whereas, in the FAO+ group, we found more patients with a delay >5 years between symptoms onset and correct asthma diagnosis (<i>p</i> < 0.05). ACT at T0 and ΔT0-T1, FEV1 at ΔT0-T1 and number of exacerbations at T0 and ΔT0-T1 did not differ between groups. Despite a widespread perception of FAO, per se, as a severity factor for asthma, we found similar severity profiles and amelioration after one year of treatment in the FAO+ and FAO- groups. The only factor linked to FAO development in our population was a delay in asthma diagnosis from respiratory symptoms onset, which may have led to airway remodeling. Physicians should characterize patients with FAO for avoiding misdiagnosis between asthma and other respiratory diseases and for establishing the appropriate therapy.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 1","pages":"66-73"},"PeriodicalIF":1.8,"publicationDate":"2023-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10791806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deciphering Microbiota of Acute Upper Respiratory Infections: A Comparative Analysis of PCR and mNGS Methods for Lower Respiratory Trafficking Potential.","authors":"Sadia Almas,&nbsp;Rob E Carpenter,&nbsp;Anuradha Singh,&nbsp;Chase Rowan,&nbsp;Vaibhav K Tamrakar,&nbsp;Rahul Sharma","doi":"10.3390/arm91010006","DOIUrl":"https://doi.org/10.3390/arm91010006","url":null,"abstract":"<p><p>Although it is clinically important for acute respiratory tract (co)infections to have a rapid and accurate diagnosis, it is critical that respiratory medicine understands the advantages of current laboratory methods. In this study, we tested nasopharyngeal samples (<i>n</i> = 29) with a commercially available PCR assay and compared the results with those of a hybridization-capture-based mNGS workflow. Detection criteria for positive PCR samples was Ct < 35 and for mNGS samples it was >40% target coverage, median depth of 1X and RPKM > 10. A high degree of concordance (98.33% PPA and 100% NPA) was recorded. However, mNGS yielded positively 29 additional microorganisms (23 bacteria, 4 viruses, and 2 fungi) beyond PCR. We then characterized the microorganisms of each method into three phenotypic categories using the IDbyDNA Explify^® Platform (Illumina^® Inc, San Diego, CA, USA) for consideration of infectivity and trafficking potential to the lower respiratory region. The findings are significant for providing a comprehensive yet clinically relevant microbiology profile of acute upper respiratory infection, especially important in immunocompromised or immunocompetent with comorbidity respiratory cases or where traditional syndromic approaches fail to identify pathogenicity. Accordingly, this technology can be used to supplement current syndrome-based tests, and data can quickly and effectively be phenotypically characterized for trafficking potential, clinical (co)infection, and comorbid consideration-with promise to reduce morbidity and mortality.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 1","pages":"49-65"},"PeriodicalIF":1.8,"publicationDate":"2023-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10782416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis.","authors":"Yihang Zhang,&nbsp;Jiazhen Wang","doi":"10.3390/arm91010005","DOIUrl":"https://doi.org/10.3390/arm91010005","url":null,"abstract":"<p><p>The respiratory system is a well-organized multicellular organ, and disruption of cellular homeostasis or abnormal tissue repair caused by genetic deficiency and exposure to risk factors lead to life-threatening pulmonary disease including idiopathic pulmonary fibrosis (IPF). Although there is no clear etiology as the name reflected, its pathological progress is closely related to uncoordinated cellular and molecular signals. Here, we review the advances in our understanding of the role of lung tissue cells in IPF pathology including epithelial cells, mesenchymal stem cells, fibroblasts, immune cells, and endothelial cells. These advances summarize the role of various cell components and signaling pathways in the pathogenesis of idiopathic pulmonary fibrosis, which is helpful to further study the pathological mechanism of the disease, provide new opportunities for disease prevention and treatment, and is expected to improve the survival rate and quality of life of patients.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 1","pages":"26-48"},"PeriodicalIF":1.8,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952569/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10791805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}